Evidence map›Paper›PMID 38911337›Full record

ReviewClinical, cosmetic and investigational dermatology2024

A Comprehensive Review of Non-Surgical Treatments for Hypertrophic and Keloid Scars in Skin of Color.

Joshua Bronte, Crystal Zhou, Abhinav Vempati, Curtis Tam, Jeffrey Khong, Sanam Hazany, Salar Hazany

Abstract readReview
In one paragraph

Review in Clinical, cosmetic and investigational dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Features of Skin of Color.Deutsches Arzteblatt international · 2026
    Review
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joshua BronteDepartment of Research, Scar Healing Institute, Los Angeles, CA, USA.ORCID 0009-0004-5878-7798
Crystal ZhouDepartment of Research, Scar Healing Institute, Los Angeles, CA, USA.ORCID 0000-0002-9540-2904
Abhinav VempatiDepartment of Research, Scar Healing Institute, Los Angeles, CA, USA.ORCID 0000-0002-2537-0214
Curtis TamDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0003-4504-2442
Jeffrey KhongDepartment of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-7342-1581
Sanam HazanyDepartment of Research, Scar Healing Institute, Los Angeles, CA, USA.
Salar HazanyDepartment of Research, Scar Healing Institute, Los Angeles, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertrophic and keloid scars are fibroproliferative growths resulting from aberrant wound healing. Individuals with Fitzpatrick skin types (FSTs) IV-VI are particularly predisposed to hypertrophic and keloid scarring, yet specific guidelines for these populations are still lacking within the literature. Therefore, this comprehensive review provides a list of various treatments and considerations for hypertrophic and keloid scarring in patients with skin of color. We constructed a comprehensive PubMed search term and performed quadruple-blinded screening on all resulting studies to achieve this objective. Our findings demonstrate 1) the lack of efficacious treatments for raised scars within this population and 2) the need to empirically investigate individualized and multimodal therapeutic options for those with skin of color.

Indexed as

5-FUbleomycincorticosteroidFST IV-VIlaserskin of color

Identifiers

PMID38911337
PMCPMC11193462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.